Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer

NCT: NCT05704283 · RECRUITING

NCT IDNCT05704283
StatusRECRUITING
Start Date2023-02-14
Completion2027-06-01
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.

Frequently Asked Questions

What is 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer?

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer is a clinical trial registered under NCT05704283. Current status: RECRUITING.

What is the status of NCT05704283?

The current status of NCT05704283 (3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer) is: RECRUITING.

When did 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer start?

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer started on 2023-02-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑